Tirzepatide 10mg is a high-purity peptide compound developed as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative molecule demonstrates superior efficacy in glucose control and weight management compared to single-receptor agonists.
The molecular structure of tirzepatide 10mg features a lysine side chain with PEG modification, enhancing water solubility while maintaining biological activity. Clinical studies have shown significant weight loss results, with the 10mg dose demonstrating an average 19.5% reduction in body weight after 72 weeks of treatment.
As a research compound, tirzepatide 10mg offers scientists a powerful tool for studying metabolic disorders. The peptide's dual agonist mechanism provides unique opportunities to investigate novel pathways in diabetes treatment and obesity management.
Our tirzepatide 10mg is supplied in sterile vials with guaranteed purity and stability. Each batch undergoes rigorous quality control testing to ensure consistency and performance in research applications.
The peptide demonstrates excellent stability when stored properly in cool, dry conditions away from light. For long-term preservation, we recommend storage at -20°C with protection from moisture.
This product is intended for research purposes only. Not for human consumption. Researchers should follow all applicable safety protocols when handling tirzepatide 10mg.